Glucose-induced insulin secretion uremia effects aminophylline infusion glucose loads mechanisms responsible derangement insulin release uremia glucose metabolism different tests patients end-stage chronic renal failure tests intravenous glucose tolerance test g/kg glucose solution IVGTT IVGTT g/kg glucose solution IVGTT aminophylline infusion IVGTT patients IVGTT months thrice-weekly regular hemodialysis test plasma immunoreactive insulin IRI C-peptide glucose constant decay insulin production IRI area insulinogenic index IGI insulin resistance index RI Twenty-nine healthy volunteers normal controls IVGTT controls IVGTT uremic patients values IRI area IGI significant RI value increase IRI values IVGTT IGI values unchanged IVGTT IRI area IGI values IVGTT hemodialysis treatment IRI areas IGI predialysis period increase hemodialysis IGI increase RI changes IGI increase IGI rise IVGTT data defective insulin release uremia due decrease beta-cell glucose sensitivity functional exhaustion impaired adenyl cyclase-cAMP system important role pathogenesis abnormality 